Codexis
Biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics. Learn more
Launch date
Employees
Market cap
CAD269m
Enterprise valuation
CAD227m (Public information from Sep 2024)
Share price
$3.1 CDXS
Redwood City California (HQ)
Authorizing premium user...